|
Press Releases |
|
|
|
Friday, November 25, 2022 |
|
雅各臣公布二零二三财年中期业绩 |
从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 (「 雅各臣 」 或 「 公司 」;股份代号 2633.HK ) 今天公布公司及其附属公司(统称「集团」)于截至二零二二年九月三十日止年度(「报告期」)的中期业绩。 more info >> |
|
雅各臣公佈二零二三財年中期業績 |
從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司 (「 雅各臣 」 或 「 公司 」;股份代號 2633.HK ) 今天公佈公司及其附屬公司(統稱「集團」)於截至二零二二年九月三十日止年度(「報告期」)的中期業績。 more info >> |
|
Jacobson Pharma Announces FY2023 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
Wednesday, June 29, 2022 |
|
雅各臣公布二零二二财年全年业绩 |
从事基础药物、专科药物及品牌医疗保健品研发、生产、市场推广及销售的领先企业 ─ 雅各臣科研制药有限公司 (「 雅各臣 」或「 公司 」; 股份代号: 2633.HK )今天公布公司及其附属公司(统称「集团」)于截至二零二二年三月三十一日止年度(「二零二二财年」或「报告期」)的全年业绩。 more info >> |
|
雅各臣公佈二零二二財年全年業績 |
從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司 (「 雅各臣 」或「 公司 」; 股份代號: 2633.HK )今天公佈公司及其附屬公司(統稱「集團」)於截至二零二二年三月三十一日止年度(「二零二二財年」或「報告期」)的全年業績。 more info >> |
|
Jacobson Pharma Announces FY2022 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2022 ("FY2022" or the "Reporting Period"). more info >> |
|
Wednesday, June 15, 2022 |
|
万隆、雅各臣及健倍苗苗成立合资公司 拓展大中华区及亚洲专科药及品牌医疗保健市场 |
万隆控股集团有限公司(「万隆」,连同其附属公司「万隆集团」; 股份代号:0030.HK),其控股股东为云南白药集团股份有限公司(证券代号000538.SHE) more info >> |
|
萬隆、雅各臣及健倍苗苗成立合資公司 拓展大中華區及亞洲專科藥及品牌醫療保健市場 |
萬隆控股集團有限公司(「萬隆」,連同其附屬公司「萬隆集團」; 股份代號:0030.HK),其控股股東為雲南白藥集團股份有限公司(證券代號000538.SHE) more info >> |
|
Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia |
Ban Loong Holdings Limited ("Ban Loong", together with its subsidiaries, "Ban Loong Group"; stock code: 0030.HK), of which Yunnan Baiyao Group Co., Ltd. (stock code: 000538.SHE) is the controlling shareholder, Jacobson Pharma Corporation Limited ("Jacobson", together with its subsidiaries (excluding JBM Group) more info >> |
|
Monday, March 14, 2022 |
|
雅各臣獲主席增持股份至超過六成 |
從事基礎藥物、專科藥物及品牌醫療保健產品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司(「公司」;連同其附屬公司統稱「集團」;股份代號:2633 ) 獲集團主席岑廣業先生於二零二一年十二月十五日至二零二二年三月十四日期間 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
三菱商事、e-メタンの国際的アライアンス 「e-NG Coalition」 の設立について
Mar 19, 2024 12:30: JST
|
|
|
Discover BLUETTI AC240 All-Weather Power Solution: Power Beyond Limits, Rain or Shine
Mar 19, 2024 11:00 HKT/SGT
|
|
|
田中控股株式會社總公司搬遷 遷至創業地點茅場町的新總公司大樓
Mar 19, 2024 11:00 HKT/SGT
|
|
|
田中控股株式会社总公司搬迁 迁至创业之地茅场町的新总公司大楼
Mar 19, 2024 11:00 HKT/SGT
|
|
|
SAP與NVIDIA攜手加速推動全球企業應用生成式AI
Mar 19, 2024 10:54 HKT/SGT
|
|
|
SAP and NVIDIA to Accelerate Generative AI Adoption Across Enterprise Applications Powering Global Industries
Mar 19, 2024 10:53 HKT/SGT
|
|
|
富士通、採用計画について
Mar 19, 2024 10:30: JST
|
|
|
TANAKA 홀딩스, 본사를 창업지 카야바초 새로운 본사 빌딩으로 이전
Mar 19, 2024 10:00 HKT/SGT
|
|
|
Fujitsu Limited announces recruitment plans
Mar 19, 2024 10:34 JST
|
|
|
Raychem RPG achieves significant milestone to facilitate faster execution in electricity distribution projects with its 'Make India' initiative
Mar 19, 2024 09:00 HKT/SGT
|
|
|
Seyond to Expand LiDAR Solutions for Autonomous Vehicles with NVIDIA DriveWorks and Omniverse Integration
Mar 19, 2024 08:00: JST
|
|
|
Seyond to Expand LiDAR Solutions for Autonomous Vehicles with NVIDIA DriveWorks and Omniverse Integration
Mar 19, 2024 07:00 HKT/SGT
|
|
|
亿胜生物公布2023年度业绩,收入增长29.5%,利润增长22.1%
Mar 18, 2024 21:32 HKT/SGT
|
|
|
億勝生物公布2023年度業績,收入增長29.5%,利潤增長22.1%
Mar 18, 2024 21:31 HKT/SGT
|
|
|
Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1%
Mar 18, 2024 21:30 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|